Most-favored-nation pricing
Search documents
Trump strikes deal with US drugmakers to cut Medicaid medicine costs
The Guardian· 2025-12-19 20:14
Donald Trump and nine major pharmaceutical companies on Friday announced deals that will slash the prices of their medicines for the government’s Medicaid program and for cash payers, in his latest bid to align US costs with those in other wealthy nations.Bristol Myers Squibb, Gilead Sciences, and Merck and Roche’s US unit Genentech have struck deals. Novartis, Amgen, Boehringer Ingelheim, Sanofi and GSK have also signed on.Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid p ...
Trump secures agreements with Merck, Amgen, Novartis and others to cut drug prices under Medicaid
MINT· 2025-12-19 20:04
US President Donald Trump on Friday (December 19) announced agreements with nine major pharmaceutical companies to sharply cut the prices of medicines sold through the government’s Medicaid program and to cash-paying consumers, marking his latest push to bring US drug costs in line with those in other wealthy nations.The deals were unveiled at a White House press conference, where Trump appeared alongside senior executives from the participating drugmakers.“We were subsidizing the entire world. We’re not do ...
Pfizer to cut drug prices, announces $70 billion US investment, and discounted sales via TrumpRx
MINT· 2025-09-30 16:52
Pfizer Inc. is set to unveil plans to lower prescription drug prices at an event on Tuesday alongside President Donald Trump, according to multiple White House officials, as per a report. The announcement will include measures aimed at making medicines more affordable for Americans, particularly those enrolled in the Medicaid program, Bloomberg reported.Pfizer is expected to implement broad reductions in US drug prices, with Medicaid patients receiving “most favored nation” pricing on select medicines, the ...